ALOX5 and gastric cancer: Among the 8-gene signature of high immune cell infiltration (type C2), ALOX5 has been found to promote gastric cancer growth and attenuate chemotherapy toxicity [63], while in breast cancer, ALOX5 activation is associated with HER2 expression as well as mediates breast cancer growth and migration [64].